Get the Stockscreener App
29.30
1.42%
0.41
Twist Bioscience Corp stock is traded at $29.30, with a volume of 1.26M.
It is up +1.42% in the last 24 hours and down -26.16% over the past month.
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
See More
Previous Close:
$28.89
Open:
$28.61
24h Volume:
1.26M
Relative Volume:
1.06
Market Cap:
$1.76B
Revenue:
$277.49M
Net Income/Loss:
$-192.14M
P/E Ratio:
-8.7202
EPS:
-3.36
Net Cash Flow:
$-95.52M
1W Performance:
+3.68%
1M Performance:
-26.16%
6M Performance:
-40.42%
1Y Performance:
-28.24%
1-Day Range:
$27.78
$30.32
1-Week Range:
$27.77
$30.32
52-Week Range:
$27.12
$60.90
Twist Bioscience Corp Stock (TWST) Company Profile
Name
Twist Bioscience Corp
Sector
Industry
Phone
800-719-0671
Address
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Compare TWST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
29.30 | 1.69B | 277.49M | -192.14M | -95.52M | -3.36 |
|
TMO
Thermo Fisher Scientific Inc
|
402.82 | 148.60B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.90 | 132.07B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
513.36 | 40.34B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
111.92 | 30.82B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
140.33 | 23.70B | 15.50B | 1.33B | 2.16B | 7.34 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Jun-04-24 | Initiated | Guggenheim | Buy |
| Jan-17-24 | Upgrade | Goldman | Neutral → Buy |
| Sep-27-23 | Initiated | Berenberg | Buy |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Jan-03-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-29-21 | Initiated | William Blair | Outperform |
| Jun-04-21 | Initiated | Goldman | Neutral |
| Apr-12-21 | Initiated | Piper Sandler | Overweight |
| Feb-05-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-04-21 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-20 | Initiated | SVB Leerink | Mkt Perform |
| May-31-19 | Initiated | Evercore ISI | Outperform |
| Nov-26-18 | Initiated | JP Morgan | Neutral |
View All
Twist Bioscience Corp Stock (TWST) Latest News
Twist Bioscience Corp (TWST) Shares Gap Down to $28.2 on May 28 - GuruFocus
Twist Bioscience Co. (NASDAQ:TWST) Stake Raised by Nuveen Asset Management LLC - Defense World
Twist Bioscience Co. (NASDAQ:TWST) Shares Sold by Bank of America Corp DE - Defense World
Twist Bioscience Executives Sell Shares to Cover Tax Obligations - TradingView
Ameriprise Financial Inc. Trims Stake in Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Twist Bioscience Corp (TWST) Shares Down 5.14% on May 21 - GuruFocus
Twist Bioscience (TWST) Expands Partnership with Element Bioscie - GuruFocus
Twist Bioscience (TWST) Expands Partnership with Element Biosciences | TWST Stock News - GuruFocus
Twist Bioscience and Element Biosciences Expand Collaboration to Transform Next Generation Sequencing Workflows with Co-Developed End-to-End Solutions - Business Wire
Twist Bioscience stock hits 52-week low at $28.41 By Investing.com - Investing.com Canada
Twist Bioscience stock hits 52-week low at $28.41 - Investing.com
Twist Bioscience Corp (TWST) Stock Price Down 3.12% on May 19 - GuruFocus
Brokerages Set Twist Bioscience Co. (NASDAQ:TWST) Target Price at $50.40 - Defense World
Twist Bioscience to Present at William Blair 45th Annual Growth Stock Conference - 01net
DNA Synthesis Market to Witness Growth from Synthetic Biology - openPR.com
Stifel Financial Corp Purchases 1,364 Shares of Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Cathie Wood’s ARK adjusts positions, selling Archer Aviation, buying Twist Bioscience - Investing.com Nigeria
Cathie Wood’s ARK adjusts positions, selling Archer Aviation, buying Twist Bioscience By Investing.com - Investing.com South Africa
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire
Leerink Partnrs Cuts Earnings Estimates for Twist Bioscience - Defense World
William Blair Issues Optimistic Outlook for TWST Earnings - Defense World
Billionaire Nicholas J. Pritzker’s 8 Stocks with Huge Upside Potential - Insider Monkey
Twist Bioscience Corporation (TWST): Among Nicholas J. Pritzker’s Stock Picks with Huge Upside Potential - Yahoo Finance
Twist Bioscience and Ginkgo Bioworks update DNA supply deal - Investing.com
Twist Bioscience and Ginkgo Bioworks Revise Collaboration - Business Wire
The Goldman Sachs Group Issues Pessimistic Forecast for Twist Bioscience (NASDAQ:TWST) Stock Price - Defense World
Twist Bioscience (NASDAQ:TWST) Reaches New 52-Week Low After Earnings Miss - Defense World
Twist Bioscience: Expansion Efforts Continue To Face Challenges (NASDAQ:TWST) - Seeking Alpha
Goldman Sachs Adjusts Price Target for Twist Bioscience (TWST) | - GuruFocus
Where Twist Bioscience Stands With Analysts - Benzinga
Goldman Sachs Adjusts Price Target for Twist Bioscience (TWST) | TWST Stock News - GuruFocus
Guggenheim Reiterates Buy Rating on Twist Bioscience (TWST) with $50 Price Target | TWST Stock News - GuruFocus
Twist Bioscience (TWST) Price Target Lowered by Baird | TWST Sto - GuruFocus
Twist Bioscience (TWST) Price Target Lowered by Baird | TWST Stock News - GuruFocus
JP Morgan Adjusts Price Target for Twist Bioscience (TWST) | TWS - GuruFocus
JP Morgan Adjusts Price Target for Twist Bioscience (TWST) | TWST Stock News - GuruFocus
Twist Bioscience Corporation (NASDAQ:TWST) Q2 2025 Earnings Call Transcript - Insider Monkey
Twist Bioscience (TWST) Price Target Adjusted by Analyst | TWST Stock News - GuruFocus
JPMorgan Adjusts Price Target for Twist Bioscience (TWST) | TWST Stock News - GuruFocus
Twist Bioscience Corp (TWST) Q2 2025 Earnings Call Highlights: R - GuruFocus
Twist Bioscience Corp (TWST) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic ... - Yahoo Finance
Twist Bioscience Second Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance
Twist Bioscience stock holds $58 target, safe from headwinds By Investing.com - Investing.com Canada
Twist Bioscience: Fiscal Q2 Earnings Snapshot - MySA
Twist Bioscience (TWST) Reports Q2 Revenue and New Business Laun - GuruFocus
Twist Bioscience stock holds $58 target, safe from headwinds - Investing.com Australia
Leerink maintains $40 target on Twist Bioscience stock - Investing.com
Twist Bioscience (TWST) Unveils DNA Storage Spin-Off and Reports Strong Q2 Growth - GuruFocus
Barclays maintains $45 target on Twist Bioscience stock - Investing.com
Twist Bioscience earnings missed by $0.05, revenue topped estimates - Investing.com Canada
Twist Bioscience (TWST) Q2 Earnings: Revenue Surges but EPS Falls Short - GuruFocus
Twist Bioscience Corp Stock (TWST) Financials Data
Revenue
Net Income
Cash Flow
EPS
Twist Bioscience Corp Stock (TWST) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Cho Dennis | See Remarks |
May 21 '25 |
Sale |
29.75 |
531 |
15,796 |
105,318 |
| Green Paula | SVP of Human Resources |
May 21 '25 |
Sale |
29.75 |
632 |
18,800 |
128,748 |
| Finn Patrick John | President and COO |
May 21 '25 |
Sale |
29.75 |
1,877 |
55,835 |
240,783 |
| Leproust Emily M. | Chief Executive Officer |
May 21 '25 |
Sale |
29.75 |
2,802 |
83,351 |
649,630 |
| WERNER ROBERT F. | Chief Accounting Officer |
May 21 '25 |
Sale |
29.75 |
242 |
7,199 |
51,030 |
| Laponis Adam | Chief Financial Officer |
May 21 '25 |
Sale |
29.75 |
936 |
27,843 |
106,018 |
0.78%
1.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):